Considering that STAT5 can directly up-regulate MCL-1, representing an important anti-apoptotic protein in AML cells, 17-AAG-mediated degradation of FLT3-ITD might be an effective strategy to overcome resistance in FLT3-ITD-harboring AML [26,41]. Here, MCL1 is linked to acute myeloid leukemia.